University of Maryland
Tibial Plateau: Bread & Butter to Limb Threatening
Wednesday, October 18, 2023
2:10 PM – 2:30 PM PST
Disclosure(s): Arthrex: Consultant (Ongoing), Other Financial or Material Support (Ongoing); Elsevier: Other Financial or Material Support (Ongoing); Metalogix: Consultant (Ongoing); Restor3D: Consultant (Ongoing), ownership/equity (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing)
Thursday, October 19, 2023
10:01 AM – 10:07 AM PST
Disclosure(s): Arthrex: Consultant (Ongoing), Other Financial or Material Support (Ongoing); Elsevier: Other Financial or Material Support (Ongoing); Metalogix: Consultant (Ongoing); Restor3D: Consultant (Ongoing), ownership/equity (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing)
Thursday, October 19, 2023
2:00 PM – 3:00 PM PST
Disclosure(s): Arthrex: Consultant (Ongoing), Other Financial or Material Support (Ongoing); Elsevier: Other Financial or Material Support (Ongoing); Metalogix: Consultant (Ongoing); Restor3D: Consultant (Ongoing), ownership/equity (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing)
Return to Work After Lower Extremity Trauma: An Analysis of Patient-Reported Outcomes
Friday, October 20, 2023
2:37 PM – 2:43 PM PST
Disclosure(s): Arthrex: Consultant (Ongoing), Other Financial or Material Support (Ongoing); Elsevier: Other Financial or Material Support (Ongoing); Metalogix: Consultant (Ongoing); Restor3D: Consultant (Ongoing), ownership/equity (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing)
Management of Complex Geriatric Proximal Humerus Fractures: From Sling to Salvage
Friday, October 20, 2023
4:30 PM – 5:30 PM PST
Disclosure information not submitted.
Geriatric Acetabulum Fractures: Treatment Strategies to Prevent Catastrophic Complications
Saturday, October 21, 2023
9:45 AM – 10:45 AM PST
Disclosure(s): Arthrex: Consultant (Ongoing), Other Financial or Material Support (Ongoing); Elsevier: Other Financial or Material Support (Ongoing); Metalogix: Consultant (Ongoing); Restor3D: Consultant (Ongoing), ownership/equity (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing)